Related Experiment Video
Updated: Sep 25, 2026
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Current developments in cancer vaccines and cellular immunotherapy
Antoni Ribas1, Lisa H Butterfield, John A Glaspy
1Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, 90095-1782, USA. aribas@mednet.ucla.edu
Abstract:
This article reviews the immunologic basis of clinical trials that test means of tumor antigen recognition and immune activation, with the goal to provide the clinician with a mechanistic understanding of ongoing cancer vaccine and cellular immunotherapy clinical trials. Multiple novel immunotherapy strategies have reached the stage of testing in clinical trials that were accelerated by recent advances in the characterization of tumor antigens and by a more precise knowledge of the regulation of cell-mediated immune responses. The key steps in the generation of an immune response to cancer cells include loading of tumor antigens onto antigen-presenting cells in vitro or in vivo, presenting antigen in the appropriate immune stimulatory environment, activating cytotoxic lymphocytes, and blocking autoregulatory control mechanisms. This knowledge has opened the door to antigen-specific immunization for cancer using tumor-derived proteins or RNA, or synthetically generated peptide epitopes, RNA, or DNA. The critical step of antigen presentation has been facilitated by the coadministration of powerful immunologic adjuvants, the provision of costimulatory molecules and immune stimulatory cytokines, and the ability to culture dendritic cells. Advances in the understanding of the nature of tumor antigens and their optimal presentation, and in the regulatory mechanisms that govern the immune system, have provided multiple novel immunotherapy intervention strategies that are being tested in clinical trials.
Insights
This review explores the immunology behind cancer vaccine and cellular immunotherapy clinical trials. Understanding tumor antigen recognition and immune activation is key to developing effective cancer treatments.
Area of Science:
- Immunology
- Oncology
- Clinical Trials
Background:
- Recent advances in tumor antigen characterization and immune response regulation have accelerated novel immunotherapy strategies.
- Understanding the immunologic basis of cancer is crucial for developing effective treatments.
Purpose of the Study:
- To provide clinicians with a mechanistic understanding of ongoing cancer vaccine and cellular immunotherapy clinical trials.
- To review the immunologic basis of tumor antigen recognition and immune activation in cancer therapy.
Main Methods:
- Review of current literature on cancer immunotherapy and clinical trials.
- Analysis of the key steps in generating an immune response to cancer cells.
- Discussion of novel immunotherapy strategies and their clinical applications.
Main Results:
- Key steps in anti-cancer immune response include antigen loading, presentation, cytotoxic lymphocyte activation, and overcoming regulatory controls.
- Antigen-specific immunization strategies utilize tumor-derived or synthetic antigens (proteins, RNA, DNA).
- Enhanced antigen presentation is achieved through adjuvants, costimulatory molecules, cytokines, and dendritic cell culturing.
Conclusions:
- Advances in understanding tumor antigens and immune regulation have led to multiple novel immunotherapy strategies in clinical trials.
- Targeting tumor antigen recognition and immune activation forms the basis of modern cancer immunotherapy.
- Mechanistic insights are vital for the successful clinical translation of cancer vaccines and cellular immunotherapies.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...